MET and breast carcinoma: To address the above issues, we used the metastatic human breast cancer cell line MDA-MB-231, which has abundant MET and CDCP1 expression, and a low invasive/nonmetastatic breast cancer cell line T47D, which has no detectable expression of both mentioned proteins, as model systems.